Answers are grounded in this paper and cite their sources.
Background: Yttrium-90 radioembolization (Y-90) is an established locoregional therapy for primary and metastatic liver malignancies. Patients with prior biliary intervention may face a higher risk of infectious complications because of altered biliary anatomy and bacterial colonization. Objective: To evaluate the incidence of infectious complications after Y-90 radioembolization in patients with prior biliary intervention. Methods: PubMed, Embase, and Scopus were searched from inception to June 2026, and risk of bias was assessed for each study. Studies were synthesized descriptively, with per-study proportions and crude totals that count overlapping patients once. Results: Eight studies were included: six retrospective cohorts and two case reports. Four cohorts reported per-patient outcomes in 152 patients; one reported only per procedure, and another was a subset of a larger cohort. Hepatobiliary infection (liver abscess or cholangitis) occurred in 12 of 152 patients (7.9%), liver abscess in 10 (6.6%), cholangitis in 5 (3.3%), and sepsis with hepatobiliary infection in 8 (5.3%); 2 patients died of infection (1.3%). Conclusion: Hepatobiliary infection after Y-90 radioembolization in patients with prior biliary intervention appears less frequent than reported after chemoembolization but more frequent than with intact biliary anatomy. Radioembolization may be a reasonable option in this population.
No takes yet. Share an insight, caveat, or question.
Siddiqui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: